- Published at
- by manilatimes.net
positive
positive
ORYZON Raises €30 Million in Capital Increase
**media[604378]**
News for Oryzon Genomics S.A. (ORYN.MX)
- Published at
- by manilatimes.net
positivepositive- Published at
- by manilatimes.net
positivepositive- Published at
- by manilatimes.net
positivepositive- Published at
- by manilatimes.net
mixedmixed- Published at
- by manilatimes.net
positivepositive- Published at
- by investing.com
neutralneutralORYZON Announces First Patient Dosed in NCI-Sponsored Iadademstat in Combination With Venetoclax and Azacitidine Clinical Trial in First Line Acute Myeloid Leukemia By Investing.com
ORYZON Announces First Patient Dosed in NCI-Sponsored Iadademstat in Combination With Venetoclax and Azacitidine Clinical Trial in First Line Acute Myeloid Leukemia- Published at
- by investing.com
neutralneutralORYZON to Provide Corporate Progress Updates at Several Events in January-February By Investing.com
ORYZON to Provide Corporate Progress Updates at Several Events in January-February- Published at
- by manilatimes.net
neutralneutral- Published at
- by manilatimes.net
positivepositive- Published at
- by globenewswire.com
mixedmixedTau Inhibitors Clinical Trial Pipeline Analysis Demonstrates 25+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight
The rising incidence of Alzheimer's and other tau-related disorders, driven by an aging global population, is significantly boosting the demand for...- Published at
- by globenewswire.com
mixedmixedGlobal Corporate Wellness Market to Surpass ~USD 117 Billion by 2030 | DelveInsight
The growing demand for corporate wellness is largely driven by factors such as increased screen time, higher workloads, rapid urbanization, poor diet,...- Published at
- by globenewswire.com
mixedmixedGlobal Neuroendoscopy Market to Exhibit Growth at a CAGR of ~5% by 2030| DelveInsight
The surge in neuroendoscopy demand is chiefly fueled by the increasing occurrence of neurological conditions like brain tumors. Furthermore, the escalating...- Published at
- by globenewswire.com
mixedmixedPDE4 Inhibitor Market to Exhibit Substantial Growth Rate During the Study Period (2020–2034) | DelveInsight
The PDE4 inhibitor market is poised for substantial growth in the coming years, driven by expanding research in inflammatory and autoimmune diseases. With...- Published at
- by investing.com
neutralneutralORYZON Presents Preliminary Data From Ongoing Phase Ib FRIDA Trial with Iadademstat Plus Gilteritinib in Relapsed/Refractory FLT3-mut AML Patients at EHA-2024 By Investing.com
ORYZON Presents Preliminary Data From Ongoing Phase Ib FRIDA Trial with Iadademstat Plus Gilteritinib in Relapsed/Refractory FLT3-mut AML Patients at EHA-2024- Published at
- by globenewswire.com
mixedmixedHDAC Inhibitor Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
The prevalence of Cancer has been rising over the past few years, which prompts the growing demand for treatment options. The increasing prevalence of...- Published at
- by globenewswire.com
mixedmixedTraumatic Brain Injury Market to Register Sustainable Growth by 2032, Evaluates DelveInsight | Leading Companies in the Market - Life Molecular Imaging, Merz, Vasopharm, Pinteon, Omniscient Neurotechn
DelveInsight’s analysts estimate that the traumatic brain injury market is expected to show positive growth, mainly attributed to increasing incidence,...- Published at
- by globenewswire.com
mixedmixedSchizophrenia Market is Expected to Showcase a Significant Growth by 2032, Predicts DelveInsight | Key Companies - Otsuka, Boehringer Ingelheim, Merck, Sunivion, PsychoGenics, Neurocrine Biosciences,
The schizophrenia market is expected to grow significantly owing to an increase in the patient pool due to changes in lifestyle, an increase in the...- Published at
- by globenewswire.com
mixedmixedFrontotemporal Dementia Treatment Drug Market to Showcase Immense Growth During the Study Period (2019–2032) | DelveInsight
The overall frontotemporal dementia market is expected to rise due to increasing prevalence cases over the globe and thus the surge in treatment options....- Published at
- by globenewswire.com
mixedmixedCharcot-Marie-Tooth Disease Market Size and Share to Grow by 2032, Predicts DelveInsight | Key Players in the Market - Pharnext, MedDay, HELIXMITH, ENCell, InFlectis, Addex, Augustine, DTx Pharma
The increase in the Charcot-Marie-Tooth disease market size is a direct consequence of increasing prevalent population of Charcot-Marie-Tooth disease...